Cargando…
Role of SLC39A6 in the development and progression of liver cancer
Liver cancer is one of the most common malignant solid tumor types worldwide. The solute carrier (SLC)39A family is a main member of the SLC group of membrane transport proteins, which transfer zinc to the cytoplasm when cells are depleted of zinc; thus, it may provide a novel therapeutic target for...
Autores principales: | Wan, Zhen, Wang, Xuzhen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8771636/ https://www.ncbi.nlm.nih.gov/pubmed/35111246 http://dx.doi.org/10.3892/ol.2022.13197 |
Ejemplares similares
-
Involvement of SLC39A6 in gastric adenocarcinoma and correlation of the SLC39A6 polymorphism rs1050631 with clinical outcomes after resection
por: Gao, Jian, et al.
Publicado: (2019) -
Knockdown of SLC39A14 inhibits glioma progression by promoting erastin-induced ferroptosis SLC39A14 knockdown inhibits glioma progression
por: Zhang, Yunwen, et al.
Publicado: (2023) -
Development of camelid monoclonal nanobody against SLC39A6 zinc transporter protein
por: Ghaderi, Hajarossadat, et al.
Publicado: (2021) -
Suppression of SLC39A6‐CREB1 axis in liver cancer causes PCK1‐mediated mitochondrial dysfunction
por: Yu, Ze, et al.
Publicado: (2023) -
SLC39A6: a potential target for diagnosis and therapy of esophageal carcinoma
por: Cui, Xiao-Bin, et al.
Publicado: (2015)